Contract HHSD2002010M36118P
Asuragen Incorporated · Department Of Health And Human Services · August 31, 2010
Asuragen Incorporated was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on August 31, 2010 for $9,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Austin, TX. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 20, 2014.
Contract details
- PIID
- HHSD2002010M36118P
- Award type
- Po
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Austin, TX
- First action
- August 31, 2010
- Latest action
- February 20, 2014
Description
TAS::75 0943::TAS ARMORED RNA QUANT
Modification timeline
-
February 20, 2014Mod 1$0
-
August 31, 2010Base award$8.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2002010M36118P?
Contract HHSD2002010M36118P is a federal contract awarded to Asuragen Incorporated by Department Of Health And Human Services on August 31, 2010 for $9,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSD2002010M36118P?
Asuragen Incorporated won contract HHSD2002010M36118P from Department Of Health And Human Services.
How much is contract HHSD2002010M36118P worth?
Contract HHSD2002010M36118P has obligated $9,000 to date.